Potential osteoporosis recovery by deep sea water through bone regeneration in SAMP8 mice

Hen Yu Liu, Ming Che Liu, Ming Fu Wang, Wei Hong Chen, Ching Yu Tsai, Kuan Hsien Wu, Che Tong Lin, Ying Hua Shieh, Rong Zeng, Win Ping Deng

研究成果: 雜誌貢獻文章

15 引文 (Scopus)

摘要

The aim of this study is to examine the therapeutic potential of deep sea water (DSW) on osteoporosis. Previously, we have established the ovariectomized senescence-accelerated mice (OVX-SAMP8) and demonstrated strong recovery of osteoporosis by stem cell and platelet-rich plasma (PRP). Deep sea water at hardness (HD) 1000 showed significant increase in proliferation of osteoblastic cell (MC3T3) by MTT assay. For in vivo animal study, bone mineral density (BMD) was strongly enhanced followed by the significantly increased trabecular numbers through micro-CT examination after a 4-month deep sea water treatment, and biochemistry analysis showed that serum alkaline phosphatase (ALP) activity was decreased. For stage-specific osteogenesis, bone marrow-derived stromal cells (BMSCs) were harvested and examined. Deep sea water-treated BMSCs showed stronger osteogenic differentiation such as BMP2, RUNX2, OPN, and OCN, and enhanced colony forming abilities, compared to the control group. Interestingly, most untreated OVX-SAMP8 mice died around 10 months; however, approximately 57% of DSW-treated groups lived up to 16.6 months, a life expectancy similar to the previously reported life expectancy for SAMR1 24 months. The results demonstrated the regenerative potentials of deep sea water on osteogenesis, showing that deep sea water could potentially be applied in osteoporosis therapy as a complementary and alternative medicine (CAM).
原文英語
文章編號161976
期刊Evidence-based Complementary and Alternative Medicine
2013
DOIs
出版狀態已發佈 - 2013

指紋

Bone Regeneration
Seawater
Osteoporosis
Complementary Therapies
Life Expectancy
Mesenchymal Stromal Cells
Osteogenesis
Platelet-Rich Plasma
Water Purification
Hardness
Biochemistry
Bone Density
Alkaline Phosphatase
Stem Cells
Cell Proliferation
Control Groups
Therapeutics
Serum

ASJC Scopus subject areas

  • Complementary and alternative medicine

引用此文

Potential osteoporosis recovery by deep sea water through bone regeneration in SAMP8 mice. / Liu, Hen Yu; Liu, Ming Che; Wang, Ming Fu; Chen, Wei Hong; Tsai, Ching Yu; Wu, Kuan Hsien; Lin, Che Tong; Shieh, Ying Hua; Zeng, Rong; Deng, Win Ping.

於: Evidence-based Complementary and Alternative Medicine, 卷 2013, 161976, 2013.

研究成果: 雜誌貢獻文章

Liu, Hen Yu ; Liu, Ming Che ; Wang, Ming Fu ; Chen, Wei Hong ; Tsai, Ching Yu ; Wu, Kuan Hsien ; Lin, Che Tong ; Shieh, Ying Hua ; Zeng, Rong ; Deng, Win Ping. / Potential osteoporosis recovery by deep sea water through bone regeneration in SAMP8 mice. 於: Evidence-based Complementary and Alternative Medicine. 2013 ; 卷 2013.
@article{01ee33ba998849fca7fa770d47d7cde6,
title = "Potential osteoporosis recovery by deep sea water through bone regeneration in SAMP8 mice",
abstract = "The aim of this study is to examine the therapeutic potential of deep sea water (DSW) on osteoporosis. Previously, we have established the ovariectomized senescence-accelerated mice (OVX-SAMP8) and demonstrated strong recovery of osteoporosis by stem cell and platelet-rich plasma (PRP). Deep sea water at hardness (HD) 1000 showed significant increase in proliferation of osteoblastic cell (MC3T3) by MTT assay. For in vivo animal study, bone mineral density (BMD) was strongly enhanced followed by the significantly increased trabecular numbers through micro-CT examination after a 4-month deep sea water treatment, and biochemistry analysis showed that serum alkaline phosphatase (ALP) activity was decreased. For stage-specific osteogenesis, bone marrow-derived stromal cells (BMSCs) were harvested and examined. Deep sea water-treated BMSCs showed stronger osteogenic differentiation such as BMP2, RUNX2, OPN, and OCN, and enhanced colony forming abilities, compared to the control group. Interestingly, most untreated OVX-SAMP8 mice died around 10 months; however, approximately 57{\%} of DSW-treated groups lived up to 16.6 months, a life expectancy similar to the previously reported life expectancy for SAMR1 24 months. The results demonstrated the regenerative potentials of deep sea water on osteogenesis, showing that deep sea water could potentially be applied in osteoporosis therapy as a complementary and alternative medicine (CAM).",
author = "Liu, {Hen Yu} and Liu, {Ming Che} and Wang, {Ming Fu} and Chen, {Wei Hong} and Tsai, {Ching Yu} and Wu, {Kuan Hsien} and Lin, {Che Tong} and Shieh, {Ying Hua} and Rong Zeng and Deng, {Win Ping}",
year = "2013",
doi = "10.1155/2013/161976",
language = "English",
volume = "2013",
journal = "Evidence-based Complementary and Alternative Medicine",
issn = "1741-427X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Potential osteoporosis recovery by deep sea water through bone regeneration in SAMP8 mice

AU - Liu, Hen Yu

AU - Liu, Ming Che

AU - Wang, Ming Fu

AU - Chen, Wei Hong

AU - Tsai, Ching Yu

AU - Wu, Kuan Hsien

AU - Lin, Che Tong

AU - Shieh, Ying Hua

AU - Zeng, Rong

AU - Deng, Win Ping

PY - 2013

Y1 - 2013

N2 - The aim of this study is to examine the therapeutic potential of deep sea water (DSW) on osteoporosis. Previously, we have established the ovariectomized senescence-accelerated mice (OVX-SAMP8) and demonstrated strong recovery of osteoporosis by stem cell and platelet-rich plasma (PRP). Deep sea water at hardness (HD) 1000 showed significant increase in proliferation of osteoblastic cell (MC3T3) by MTT assay. For in vivo animal study, bone mineral density (BMD) was strongly enhanced followed by the significantly increased trabecular numbers through micro-CT examination after a 4-month deep sea water treatment, and biochemistry analysis showed that serum alkaline phosphatase (ALP) activity was decreased. For stage-specific osteogenesis, bone marrow-derived stromal cells (BMSCs) were harvested and examined. Deep sea water-treated BMSCs showed stronger osteogenic differentiation such as BMP2, RUNX2, OPN, and OCN, and enhanced colony forming abilities, compared to the control group. Interestingly, most untreated OVX-SAMP8 mice died around 10 months; however, approximately 57% of DSW-treated groups lived up to 16.6 months, a life expectancy similar to the previously reported life expectancy for SAMR1 24 months. The results demonstrated the regenerative potentials of deep sea water on osteogenesis, showing that deep sea water could potentially be applied in osteoporosis therapy as a complementary and alternative medicine (CAM).

AB - The aim of this study is to examine the therapeutic potential of deep sea water (DSW) on osteoporosis. Previously, we have established the ovariectomized senescence-accelerated mice (OVX-SAMP8) and demonstrated strong recovery of osteoporosis by stem cell and platelet-rich plasma (PRP). Deep sea water at hardness (HD) 1000 showed significant increase in proliferation of osteoblastic cell (MC3T3) by MTT assay. For in vivo animal study, bone mineral density (BMD) was strongly enhanced followed by the significantly increased trabecular numbers through micro-CT examination after a 4-month deep sea water treatment, and biochemistry analysis showed that serum alkaline phosphatase (ALP) activity was decreased. For stage-specific osteogenesis, bone marrow-derived stromal cells (BMSCs) were harvested and examined. Deep sea water-treated BMSCs showed stronger osteogenic differentiation such as BMP2, RUNX2, OPN, and OCN, and enhanced colony forming abilities, compared to the control group. Interestingly, most untreated OVX-SAMP8 mice died around 10 months; however, approximately 57% of DSW-treated groups lived up to 16.6 months, a life expectancy similar to the previously reported life expectancy for SAMR1 24 months. The results demonstrated the regenerative potentials of deep sea water on osteogenesis, showing that deep sea water could potentially be applied in osteoporosis therapy as a complementary and alternative medicine (CAM).

UR - http://www.scopus.com/inward/record.url?scp=84885356168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885356168&partnerID=8YFLogxK

U2 - 10.1155/2013/161976

DO - 10.1155/2013/161976

M3 - Article

C2 - 24069046

AN - SCOPUS:84885356168

VL - 2013

JO - Evidence-based Complementary and Alternative Medicine

JF - Evidence-based Complementary and Alternative Medicine

SN - 1741-427X

M1 - 161976

ER -